“…Recently, dozens of nanoagents based on various two-dimensional (2D) nanomaterials and their composites, like layered double hydroxides (LDHs), black phosphorus (BP) nanosheets, transition metal carbides (MXenes), transition metal dichalcogenides (TMDs), and carbon nitride (CN) have sprung up in catalytic tumor therapy. − Among them, CN-based hybrids have aroused great concern for their biocompatibility and optical and electrical characteristics. As a typical semiconductor, pristine CN owns a large bandgap about 2.7 eV, which brings about the difficulty of photo-induced electron–hole pair separation and thus leading to insufficient ROS generation. , During the past few years, several attempts including rational modulation of the original structure, bandgap engineering, dye sensitization, and heterojunction construction have been made to overcome this hurdle. − Meanwhile, our previous researches also have proved that constructing the semiconductor-metal (S-M) heterojunction between metallic molybdenum disulfide (1T-MoS 2 ) nanosheets and CN nanosheets or using copper doped conjugated polymers (CuPANI) to build heterostructure with CN could enhance near-infrared (NIR) light responsiveness and photocatalytic ROS generation at the same time. , The strategy to construct heterojunctions with other materials is undoubtedly advisable while retaining the property of a single component. Nonetheless, how to develop the nanoheterojunction with better catalytic performance through a relatively facile approach, and integrate other promising treatment modalities based on catalytic therapy, such as pyroptosis, ferroptosis, and cuproptosis, is definitely a great challenge. − …”